0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Gastroparesis Epidemiology Forecast to 2028
Published Date: February 2019
|
Report Code: DELV-Epid-410
Home | Market Reports | Health | Health Conditions
Gastroparesis Epidemiology Forecast to 2028

Gastroparesis Epidemiology Forecast to 2028

Code: DELV-Epid-410
Report
February 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Gastroparesis - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Gastroparesis epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Gastroparesis Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Gastroparesis in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Gastroparesis outlook. It also includes the explanation of changing trends of epidemiology outlining the Gastroparesis scenario.

Gastroparesis Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Gastroparesis thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Gastroparesis explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Gastroparesis Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Gastroparesis

Key assessments
• Patient Segmentation in Gastroparesis
• Gastroparesis Risk & Burden
• Factors driving growth in a specific Gastroparesis patient population

  1. Report Introduction
    2. Gastroparesis Epidemiology Overview at a Glance
    2.1. Patient Share Distribution of Gastroparesis in 2016
    2.2. Patient Share Distribution of Gastroparesis in 2028
    3. Disease Background and Overview: Gastroparesis
    3.1. Introduction
    3.2. Symptoms
    3.3. Etiology
    3.4. Risk Factors
    3.5. Pathophysiology
    3.6. Diagnosis
    3.7. Treatment
    4. Epidemiology and Patient Population
    4.1. Key Findings
    4.2. Total Prevalent/ Incident Patient Population of Gastroparesis in 7MM
    4.3. Total Prevalent/ Incident Patient Population of Gastroparesis in 7MM – By Countries
    5. Epidemiology of Gastroparesis by Countries
    5.1. United States
    5.1.1. Assumptions and Rationale
    5.1.2. Prevalent/Incident Cases of the Gastroparesis
    5.1.3. Sub-Type Specific cases of the Gastroparesis *
    5.1.4. Sex- Specific Cases of the Gastroparesis *
    5.1.5. Diagnosed Cases of the Gastroparesis
    5.2. EU5
    5.3. Assumptions and Rationale
    5.4. Germany
    5.4.1. Assumptions and Rationale
    5.4.2. Prevalent/Incident Cases of the Gastroparesis
    5.4.3. Sub-Type Specific cases of the Gastroparesis *
    5.4.4. Sex- Specific Cases of the Gastroparesis *
    5.4.5. Diagnosed Cases of the Gastroparesis
    5.5. France
    5.5.1. Assumptions and Rationale
    5.5.2. Prevalent/Incident Cases of the Gastroparesis
    5.5.3. Sub-Type Specific cases of the Gastroparesis *
    5.5.4. Sex- Specific Cases of the Gastroparesis *
    5.5.5. Diagnosed Cases of the Gastroparesis
    5.6. Italy
    5.6.1. Assumptions and Rationale
    5.6.2. Prevalent/Incident Cases of the Gastroparesis
    5.6.3. Sub-Type Specific cases of the Gastroparesis *
    5.6.4. Sex- Specific Cases of the Gastroparesis *
    5.6.5. Diagnosed Cases of the Gastroparesis
    5.7. Spain
    5.7.1. Assumptions and Rationale
    5.7.2. Prevalent/Incident Cases of the Gastroparesis
    5.7.3. Sub-Type Specific cases of the Gastroparesis *
    5.7.4. Sex- Specific Cases of the Gastroparesis *
    5.7.5. Diagnosed Cases of the Gastroparesis
    5.8. United Kingdom
    5.8.1. Assumptions and Rationale
    5.8.2. Prevalent/Incident Cases of the Gastroparesis
    5.8.3. Sub-Type Specific cases of the Gastroparesis *
    5.8.4. Sex- Specific Cases of the Gastroparesis *
    5.8.5. Diagnosed Cases of the Gastroparesis
    5.9. Japan
    5.9.1. Assumptions and Rationale
    5.9.2. Prevalent/Incident Cases of the Gastroparesis
    5.9.3. Sub-Type Specific cases of the Gastroparesis *
    5.9.4. Sex- Specific Cases of the Gastroparesis *
    5.9.5. Diagnosed Cases of the Gastroparesis
    6. Unmet Needs of the Gastroparesis
    7. Appendix
    8. Report Methodology
    8.1. Sources
    9. DelveInsight Capabilities
    10. Disclaimer
    11. About DelveInsight
    *Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Gastroparesis in 7MM
Table 2: Total Prevalent/Incident Cases of the Gastroparesis in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Gastroparesis in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Gastroparesis in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Gastroparesis in United States (2016-2028)*
Table 6: Diagnosed Cases of the Gastroparesis in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Gastroparesis in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Gastroparesis in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Gastroparesis in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Gastroparesis in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Gastroparesis in France (2016-2028)
Table 12: Sub-Type Specific cases of the Gastroparesis in France (2016-2028) *
Table 13: Sex- Specific Cases of the Gastroparesis in France (2016-2028) *
Table 14: Diagnosed Cases of the Gastroparesis in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Gastroparesis in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Gastroparesis in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Gastroparesis in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Gastroparesis in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Gastroparesis in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Gastroparesis in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Gastroparesis in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Gastroparesis in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Gastroparesis in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Gastroparesis in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Gastroparesis in UK (2016-2028) *
Table 26: Diagnosed Cases of the Gastroparesis in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Gastroparesis in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Gastroparesis in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Gastroparesis in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Gastroparesis in Japan (2016-2028)
List of Figures

Figure 1: Total Prevalent/Incident Cases of the Gastroparesis in 7MM
Figure 2: Total Prevalent/Incident Cases of the Gastroparesis in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Gastroparesis in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Gastroparesis in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Gastroparesis in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Gastroparesis in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Gastroparesis in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Gastroparesis in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Gastroparesis in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Gastroparesis in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Gastroparesis in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Gastroparesis in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Gastroparesis in France (2016-2028) *
Figure 14: Diagnosed Cases of the Gastroparesis in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Gastroparesis in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Gastroparesis in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Gastroparesis in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Gastroparesis in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Gastroparesis in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Gastroparesis in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Gastroparesis in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Gastroparesis in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Gastroparesis in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Gastroparesis in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Gastroparesis in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Gastroparesis in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Gastroparesis in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Gastroparesis in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Gastroparesis in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Gastroparesis in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows multiple user to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global and Japan Diabetic Eye Disease Devices Market Insights Forecast to 2027
Global and Japan Diabetic Eye Disease Devices Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-2A7205
Mon Oct 25 00:00:00 UTC 2021

Add to Cart

China Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Report Forecast 2021 2027
China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-18X6955
Mon Oct 25 00:00:00 UTC 2021

Add to Cart

China Cardiovascular and Cerebrovascular API Market Report Forecast 2021 2027
China Cardiovascular and Cerebrovascular API Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-30A6653
Mon Oct 25 00:00:00 UTC 2021

Add to Cart

China Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Report Forecast 2021 2027
China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-28V6728
Mon Oct 25 00:00:00 UTC 2021

Add to Cart